Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 USD | +0.29% | -8.68% | +8.10% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
Financials (USD)
Sales 2024 * | 42.75K | Sales 2025 * | 4.12M | Capitalization | 585M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -305M | EV / Sales 2024 * | 7,838 x |
Net cash position 2024 * | 250M | Net cash position 2025 * | 284M | EV / Sales 2025 * | 73.1 x |
P/E ratio 2024 * |
-2.06
x | P/E ratio 2025 * |
-2.08
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Allogene Therapeutics, Inc.
1 day | +0.29% | ||
1 week | -8.68% | ||
Current month | -22.37% | ||
1 month | -20.96% | ||
3 months | +12.30% | ||
6 months | +16.44% | ||
Current year | +8.10% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
David Chang
FOU | Founder | 64 | 18-03-31 |
Geoffrey Parker
DFI | Director of Finance/CFO | 59 | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Bonderman
BRD | Director/Board Member | 81 | 18-04-30 |
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
Arie Belldegrun
FOU | Founder | 74 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.54% | 2 M€ | -25.75% | ||
0.08% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3.46 | -1.42% | 1,245,819 |
24-04-17 | 3.51 | +0.29% | 2,507,828 |
24-04-16 | 3.5 | -1.41% | 1,388,064 |
24-04-15 | 3.55 | -6.58% | 1,592,742 |
24-04-12 | 3.8 | -4.76% | 2,882,301 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.10% | 585M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- ALLO Stock